| abstract |
FIELD: chemistry.SUBSTANCE: invention relates to a compound of formula (I),in which: A is phenyl, naphthyl or pyridyl; X is CH or N; Rare independently selected from group comprising (1) hydrogen, (2) halogen, (3) Calkyl, where alkyl is unsubstituted or substituted with one or more substitutes independently selected from halogen, (4) -OCalkyl, where alkyl is unsubstituted, and (5) -CN; Ris hydrogen or Calkyl, where alkyl is unsubstituted or substituted with one or more substitutes independently selected from halogen; p is 1 or 2; or a pharmaceutically acceptable salt thereof.EFFECT: compounds can be used in therapy as modulator of secretion growth hormone receptor (also called ghrelin receptor or GHSRla receptor).25 cl, 7 tbl, 28 ex |